WIPPES Act

WRDA 2024 Clean water infrastructure funding S. 1430/HR 7944: Water Systems PFAS Liability Protection Act S. 2830/HR 8032: Low-Income Household Water Assistance Program Establishment Act S. 1350/HR 2964: Wastewater Infrastructure Pollution Prevention and Environmental Safety Act

Client expense: Not reported · Firm income: $20,000

Government targets: SENATE

FDA sunscreen regulation; H.R. 2964/S. 1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety Act (WIPPES Act); H.R. 3620, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023; H.R. 3619, Toxic-Free Beauty Act of 2023; H.R. 3621, Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023; H.R. 3622, Cosmetic Supply Chain Transparency Act of 2023; S. 2934/H.R. 8684, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2023; H.R. 6519, No PFAS in Cosmetics Act; Modernization of Cosmetics Regulations Act (MoCRA) implementation; H.Res. 365, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection; legislation related to microplastics in personal care products; H.R. 8360, To amend the Federal Food Drug and Cosmetic Act to deem any sunscreen or cosmetic containing parabens to be adulterated; S.Res 736, A resolution recognizing the importance of trademarks in the economy and the role of trademarks in protecting consumer safety by designating the month of July as "National Anti-Counterfeiting and Consumer Education and Awareness Month"; Microplastics in personal care products legislation

Client expense: $80,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Support of labeling requirements of wipes to avoid improper disposal into wastewater treatment systems (H.R. 2964 and S.1350). Monitor status of biosolids PFAS risk assessment model development. Support of Low Income Household Water Assistance Program Establishment Act, S. 3830 and H.R. 8032. Support of finalization of Environmental Infrastructure water supply project agreement with USACE.

Client expense: Not reported · Firm income: $30,000

Government targets: Army, Dept of (Corps of Engineers), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of source control requirements related to PFAS discharge and management. Support of H.R. 2964 and S. 1350, legislation to require labeling for disposable and flushable wipes. Monitor development of risk assessment model for biosolids. Support of liability protection from PFAS CERCLA designation, H.R. 7944 and S. 1430. Monitoring status of biosolids PFAS risk assessment model development.

Client expense: Not reported · Firm income: $20,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of H.R. 2964/S. 1350, legislation to require labeling of flushable wipes to prevent improper disposal of used wipes. Support of H.R. 1181 and H.R. 7023, Creating Confidence in Clean Water Permitting Act related to ten year permits Monitor PFAS cleanup legislations Monitor development of biosolids risk assessment model

Client expense: Not reported · Firm income: $30,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 7944 -Water Systems PFAS Liability Protection Act - To protect public works employees so they do not bear brunt of cost for PFAS. H.R. 8812 Water Resources Development Act - pertinent to water and public works H.R. 2964 and S. 1350 - Wastewater Infrastructure Pollution Prevention and Environmental Safety Act (WIPPES) - to eliminate clogging in water systems. H.R. 1181 - Extends maximum term for NPDES permits issued to states and municipalities from 5 to 10 years. Important for our members for planning and certainty.

Client expense: $5,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

Client expense: Not reported · Firm income: $220,119

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2964/S.1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act (generally, no specific provisions)

Client expense: $190,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA sunscreen regulation; H.R. 2964/S. 1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety Act (WIPPES Act); H.R. 3620, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023; H.R. 3619, Toxic-Free Beauty Act of 2023; H.R. 3621, Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023; H.R. 3622, Cosmetic Supply Chain Transparency Act of 2023; S. 2934/H.R. 8684, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2023; H.R. 6519, No PFAS in Cosmetics Act; Modernization of Cosmetics Regulations Act (MoCRA) implementation; H.Res. 365, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection; legislation related to microplastics in personal care products; H.R. 8360, To amend the Federal Food Drug and Cosmetic Act to deem any sunscreen or cosmetic containing parabens to be adulterated; S.Res 736, A resolution recognizing the importance of trademarks in the economy and the role of trademarks in protecting consumer safety by designating the month of July as "National Anti-Counterfeiting and Consumer Education and Awareness Month"; Microplastics in personal care products legislation

Client expense: $100,000 · Firm income: Not reported

WRDA 2024 Clean water infrastructure funding S. 1430/HR 7944: Water Systems PFAS Liability Protection Act S. 2830/HR 8032: Low-Income Household Water Assistance Program Establishment Act S. 1350/HR 2964: Wastewater Infrastructure Pollution Prevention and Environmental Safety Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support of labeling requirements of wipes to avoid improper disposal into wastewater treatment systems (H.R. 2964 and S.1350). Monitor status of biosolids PFAS risk assessment model development. Support of Low Income Household Water Assistance Program Establishment Act, S. 3830 and H.R. 8032. Support of finalization of Environmental Infrastructure water supply project agreement with USACE.

Client expense: Not reported · Firm income: $30,000

Government targets: Army, Dept of (Corps of Engineers), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of source control requirements related to PFAS discharge and management. Support of H.R. 2964 and S. 1350, legislation to require labeling for disposable and flushable wipes. Monitor development of risk assessment model for biosolids. Support of liability protection from PFAS CERCLA designation, H.R. 7944 and S. 1430. Monitoring status of biosolids PFAS risk assessment model development

Client expense: Not reported · Firm income: $20,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of H.R. 2964/S. 1350, legislation to require labeling of flushable wipes to prevent improper disposal of used wipes. Support of H.R. 1181 and H.R. 7023, Creating Confidence in Clean Water Permitting Act related to ten year permits Monitor PFAS cleanup legislation Monitor PFAS monitoring requirements Monitor PFAS Drinking Water MCL rulemaking Monitor development of biosolids risk assessment model

Client expense: Not reported · Firm income: $30,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

Client expense: Not reported · Firm income: $118,712

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

-S. 1350 and H.R. 2964, the Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act -Issues related to new chemical approvals

Client expense: $810,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.2964/S.1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act (generally, no specific provisions) Issues related to environment and sustainability (generally, no specific legislation)

Client expense: $310,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General monitoring of legislative and administrative action related to climate change; and General monitoring of legislative and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of legislative and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings; and H.R. 2964/S.1350 Wastewater Infrastructure Pollution Prevention and Environmental Safety Act/WIPPES Act

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FDA sunscreen regulation; H.R. 2964/S. 1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety Act (WIPPES Act); H.R. 3620, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023; H.R. 3619, Toxic-Free Beauty Act of 2023; H.R. 3621, Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023; H.R. 3622, Cosmetic Supply Chain Transparency Act of 2023; S. 2934, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2023; H.R. 6519, No PFAS in Cosmetics Act; Modernization of Cosmetics Regulations Act (MoCRA) implementation; H.Res. 365, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection; legislation related to microplastics in personal care products; H.R. 8360, To amend the Federal Food Drug and Cosmetic Act to deem any sunscreen or cosmetic containing parabens to be adulterated; S.Res 736, A resolution recognizing the importance of trademarks in the economy and the role of trademarks in protecting consumer safety by designating the month of July as "National Anti-Counterfeiting and Consumer Education and Awareness Month";

Client expense: $130,000 · Firm income: Not reported

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

Client expense: Not reported · Firm income: $163,498

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Support of labeling requirements of wipes to avoid improper disposal into wastewater treatment systems (H.R. 2964 and S.1350). Monitor finalization of rulemakings for PFAS drinking water Maximum Contaminant Level standard and designation of PFAS as hazardous substance under CERCLA. Support of Low Income Household Water Assistance Program Establishment Act, S. 3830 and H.R. 8032. Support of finalization of Environmental Infrastructure water supply project agreement with USACE.

Client expense: Not reported · Firm income: $30,000

Government targets: Army, Dept of (Corps of Engineers), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of source control requirements related to PFAS discharge and management. Support of H.R. 2964 and S. 1350, legislation to require labeling for disposable and flushable wipes. Monitor development of risk assessment model for biosolids. Support of liability protection from PFAS CERCLA designation, H.R. 7944 and S. 1430. Support of ten year NPDES Permits, Confidence in Clean Water Permitting Act, H.R. 7023

Client expense: Not reported · Firm income: $20,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of H.R. 2964/S. 1350, legislation to require labeling of flushable wipes to prevent improper disposal of used wipes. Support of H.R. 1181 and H.R. 7023, Creating Confidence in Clean Water Permitting Act related to ten year permits Monitor PFAS cleanup legislation Monitor PFAS monitoring requirements Monitor PFAS Drinking Water MCL rulemaking Monitor development of biosolids risk assessment model

Client expense: Not reported · Firm income: $30,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

-Issues related to environmental sustainability -S.1350: WIPPES Act -H.R.2964: WIPPES Act

Client expense: $720,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

FDA sunscreen regulation; H.R. 2964/S. 1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety Act (WIPPES Act); H.R. 3620, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023; H.R. 3619, Toxic-Free Beauty Act of 2023; H.R. 3621, Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023; H.R. 3622, Cosmetic Supply Chain Transparency Act of 2023; S. 2934, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2023; H.R. 6519, No PFAS in Cosmetics Act; Modernization of Cosmetics Regulations Act (MoCRA) implementation; H.Res. 365, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection; legislation related to microplastics in personal care products

Client expense: $120,000 · Firm income: Not reported

H.R.2964/S.1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act (generally, no specific provisions) Issues related to environment and sustainability (generally, no specific legislation)

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General monitoring of legislative and administrative action related to climate change; and General monitoring of legislative and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of legislative and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings; and H.R. 2964/S.1350 Wastewater Infrastructure Pollution Prevention and Environmental Safety Act/WIPPES Act

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

Client expense: Not reported · Firm income: $168,788

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Support of labeling requirements of wipes to avoid improper disposal into wastewater treatment systems (H.R. 2964 and S.1350). Monitor status of PFAS drinking water Maximum Contaminant Level standard and designation of PFAS as hazardous substance rulemakings. Support of Low Income Household Water Assistance Program Establishment Act, S. 3830.

Client expense: Not reported · Firm income: $20,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of source control requirements related to PFAS discharge and management. Support of H.R. 2964 and S. 1350, legislation to require labeling for disposable and flushable wipes. Monitor development of risk assessment model for biosolids

Client expense: Not reported · Firm income: $20,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of H.R. 2964/S. 1350, legislation to require labeling of flushable wipes to prevent improper disposal of used wipes. Support of H.R. 1181 and H.R. 7023, Creating Confidence in Clean Water Permitting Act related to ten year permits Monitor PFAS cleanup legislation Monitor PFAS monitoring requirements Monitor PFAS Drinking Water MCL rulemaking Monitor development of biosolids risk assessment model

Client expense: Not reported · Firm income: $30,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2964/S.1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act (generally, no specific provisions) Issues related to environment and sustainability (generally, no specific legislation)

Client expense: $150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the safety of cosmetics, counterfeit products, and FDA sunscreen regulation; H.R. 2964/S. 1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety Act (WIPPES Act); H.R. 3620, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023; H.R. 3619, Toxic-Free Beauty Act of 2023; H.R. 3621, Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023; H.R. 3622, Cosmetic Supply Chain Transparency Act of 2023; S. 2934, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2023; H.R. 6519, No PFAS in Cosmetics Act; Modernization of Cosmetics Regulations Act (MoCRA) implementation; H.Res. 365, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection

Client expense: $240,000 · Firm income: Not reported

-S.1350: WIPPES Act -H.R.2964: WIPPES Act -Issues related to environmental sustainability

Client expense: $740,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 5978: Cleaning Product Ingredient Communication Act - federal cleaning product ingredient labeling legislation H.R. 2964 / S.1350: Wastewater Infrastructure Pollution Prevention and Environmental Safety Act - labeling requirements for flushable wipes packaging

Client expense: $79,373 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Chino Basin Program. PFOS/PFAS regulations. FEMA BRIC program. Support for Water Efficiency, Conservation and Sustainability Act (H.R. 5016 and S. 2654). Support for WIPPES Act (H.R. 2964/S. 1350); Nitrate issues.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General monitoring of legislative and administrative action related to climate change; and General monitoring of legislative and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of legislative and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings; and H.R. 2964/S.1350 Wastewater Infrastructure Pollution Prevention and Environmental Safety Act/WIPPES Act

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas

Client expense: Not reported · Firm income: $193,731

Government targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Support of labeling requirements of wipes to avoid improper disposal into wastewater treatment systems (H.R. 2964 and S.1350). Monitor status of PFAS drinking water standard and designation of PFAS as hazardous substance rulemakings.

Client expense: Not reported · Firm income: $20,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Support of source control requirements related to PFAS discharge and management. Support of H.R. 2964 and S. 1350, legislation to require labeling for disposable and flushable wipes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor development of Waters of the U.S. rulemaking. Support of H.R. 2964/S. 1350, legislation to require labeling of flushable wipes to prevent improper disposal of used wipes. Monitor PFAS cleanup legislation Monitor PFAS monitoring requirements

Client expense: Not reported · Firm income: $30,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R.2964/S.1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act (generally, no specific provisions) Issues related to environment and sustainability (generally, no specific legislation)

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General monitoring of legislative and administrative action related to climate change; and General monitoring of legislative and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of legislative and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings; and H.R. 2964/S.1350 Wastewater Infrastructure Pollution Prevention and Environmental Safety Act/WIPPES Act

Client expense: $190,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the safety of cosmetics, counterfeit products, PFAS ban and FDA sunscreen regulation; H.R. 2964/S. 1350, Wastewater Infrastructure Pollution Prevention and Environmental Safety Act (WIPPES Act); H.R. 3620, Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023; H.R. 3619, Toxic-Free Beauty Act of 2023; H.R. 3621, Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023; H.R. 3622, Cosmetic Supply Chain Transparency Act of 2023; S. 2934, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act of 2023; Modernization of Cosmetics Regulations Act (MoCRA) implementation; H.Res. 365, Supporting State, local, and community initiatives to encourage parents, teachers, camp counselors, and childcare professionals to take measures to prevent sunburns in the minors they care for, and expressing the sense of the House of Representatives that State, local, and community entities should continue to support efforts to curb the incidences of skin cancer beginning with childhood skin protection

Client expense: $220,000 · Firm income: Not reported

Support of labeling requirements of wipes to avoid improper disposal into wastewater treatment systems, H.R. 2964, S.1350. Monitor status of Waters of the U.S. rulemaking.

Client expense: Not reported · Firm income: $20,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee

Client expense: Not reported · Firm income: $160,780

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Support of source control requirements related to PFAS management. Support of funding assistance for PFAS destruction technologies. Support of H.R. 2964 and S. 1350, legislation to require labeling for disposable and flushable wipes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE